Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/221
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDr. Amitava, Bandhu-
dc.date.accessioned2021-07-06T13:50:07Z-
dc.date.available2021-07-06T13:50:07Z-
dc.date.issued2010-05-26-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/221-
dc.description.abstractPreviously, various inhibitors of cell wall synthesis induced the drp35 gene of Staphylococcus aureus efficiently. To determine whether drp35 could be exploited in antistaphylococcal drug discovery, we cloned the promoter of drp35 (Pd) and devel oped different biological assay systems using an engineered S. aureus strain that harbors a chromosomally-integrated Pd - lacZ transcriptional fusion. An agarose-based assay showed that Pd is induced not only by the cell wall-affecting antibiotics but al so by rifampicin and ciprofloxacin. In contrast, a liquid me dium-based assay revealed the induction of Pd specifically by the cell wall-affecting antibiotics. Induction of Pd by sublethal concentrations of cell wall-affecting antibiotics was even as sessable in a microtiter plate assay format, indicating that this assay system could be potentially used for high-throughput screening of new cell wall-inhibiting compounds. [BMB re ports 2010; 43(7): 468-473]en_US
dc.language.isoenen_US
dc.publisherBMB reportsen_US
dc.subjectAgarose-based assay and microtiter plate assayen_US
dc.subjectcell wall-affecting antibioticsen_US
dc.subjectdrp35en_US
dc.subjectStaphylococcus aureusen_US
dc.titleDetection of the cell wall-affecting antibiotics at sublethal concentrations using a reporter Staphylococcus aureus harboring drp35 promoter - lacZ transcriptional fusionen_US
dc.typeArticleen_US
Appears in Collections:Biotechnology



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.